These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2944784)

  • 1. Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice.
    Nomikos IN; Prowse SJ; Carotenuto P; Lafferty KJ
    Diabetes; 1986 Nov; 35(11):1302-4. PubMed ID: 2944784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desferrioxamine treatment prevents chronic islet allograft damage.
    Bradley B; Prowse SJ; Bauling P; Lafferty KJ
    Diabetes; 1986 May; 35(5):550-5. PubMed ID: 3082702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen free-radical scavengers and immune destruction of murine islets in allograft rejection and multiple low-dose streptozocin-induced insulitis.
    Mendola J; Wright JR; Lacy PE
    Diabetes; 1989 Mar; 38(3):379-85. PubMed ID: 2521836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of FK 506 on islet allograft rejection in mice and pigs.
    Nagata M; Yamaguchi T; Stein E; Mullen Y; Ochiai T
    Transplant Proc; 1991 Dec; 23(6):3213-6. PubMed ID: 1750090
    [No Abstract]   [Full Text] [Related]  

  • 5. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
    Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of hyperglycemia on the primary function of allogeneic islet transplants.
    Makhlouf L; Duvivier-Kali VF; Bonner-Weir S; Dieperink H; Weir GC; Sayegh MH
    Transplantation; 2003 Aug; 76(4):657-64. PubMed ID: 12973104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.
    Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH
    Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
    Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
    Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody.
    Stegall MD; Loberman Z; Ostrowska A; Coulombe M; Gill RG
    J Surg Res; 1996 Aug; 64(2):156-60. PubMed ID: 8812627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.
    Yang Z; Chen M; Ellett JD; Fialkow LB; Carter JD; Nadler JL
    Transplantation; 2004 Jan; 77(1):55-60. PubMed ID: 14724435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta prevents islet allograft rejection.
    Gill RG
    Transplant Proc; 1991 Feb; 23(1 Pt 1):747-8. PubMed ID: 1990676
    [No Abstract]   [Full Text] [Related]  

  • 15. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.
    Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG
    Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of H-2 compatibility on pancreatic beta cell survival in the nonobese diabetic mouse.
    Terada M; Salzler M; Lennartz K; Mullen Y
    Transplantation; 1988 Mar; 45(3):622-7. PubMed ID: 3126571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
    Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Toll-like receptors in allogeneic islet transplantation.
    Ro H; Hong J; Kim BS; Lee EW; Kim MG; Han KH; Yeom HJ; Lee EM; Jeong JC; Oh KH; Ahn C; Yang J
    Transplantation; 2012 Nov; 94(10):1005-12. PubMed ID: 23169223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.